Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the recipient of some unusual options trading on Tuesday. Stock traders purchased 22,980 call options on the company. This represents an increase of approximately 69% compared to the average volume of 13,593 call options.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on TDOC. Barclays raised their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the company an “overweight” rating in a report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft raised their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Royal Bank of Canada boosted their price objective on shares of Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Jefferies Financial Group raised their target price on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. Finally, Evercore ISI lifted their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Fourteen equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $12.24.

Teladoc Health Stock Up 0.3 %

Shares of Teladoc Health stock traded up $0.03 during trading on Tuesday, reaching $9.96. 2,357,082 shares of the company traded hands, compared to its average volume of 3,151,970. The firm has a market capitalization of $1.71 billion, a PE ratio of -1.73 and a beta of 1.01. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $22.16. The company has a 50 day moving average price of $9.90 and a 200-day moving average price of $9.03. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating the consensus estimate of ($0.29) by $0.10. The firm had revenue of $640.51 million for the quarter, compared to analyst estimates of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities research analysts expect that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of hedge funds have recently added to or reduced their stakes in the company. Versant Capital Management Inc lifted its stake in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after buying an additional 2,441 shares in the last quarter. TCW Group Inc. acquired a new position in Teladoc Health during the 3rd quarter valued at about $2,464,000. Geode Capital Management LLC boosted its stake in Teladoc Health by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock valued at $36,042,000 after purchasing an additional 56,864 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in Teladoc Health during the 3rd quarter worth approximately $152,000. Finally, Quantinno Capital Management LP raised its stake in shares of Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock worth $1,709,000 after purchasing an additional 122,050 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.